Scientific presentations
Pharmacist intervention may help identify potential opioid abuse early
Concurrent drug utilization review catches opioid abuse upstream
July 21, 2016
Concurrent drug utilization review (DUR) may cast wider net for catching potential opioid abuse upstream
A pharmacist intervention (DUR) may impact potential opioid misuse and abuse. This study identified at-risk members at the time they submit their opioid prescription. A soft edit (point of service) intervention delayed or altered claims for 42% of the members in the study.
Impact of a Concurrent Drug Utilization Review Edit Designed to Curb Opioid Misuse (Spring 2016)
Related research
Scientific presentations
August 21, 2021
Real-world CAR-T treatment costs can range from $700,000 to $1 million
CAR-T treatment costs more than the CAR-T product itself; Prime’s real-world study of…
Scientific presentations
August 1, 2021
Prime’s analytics uncovers the hidden ups and downs behind the flat drug trend for MS DMDs
Insights from integrated medical and pharmacy claims show a big upswing in one…
Scientific presentations
June 21, 2021
Break autoimmune (AI) into indication-specific info for actionable strategy
Prime uses integrated medical and pharmacy data and breaks down largest drug category…